Tranexamic Acid Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

celimax is the best-performing tranexamic acid brand in July 2026, moving 130,000 units across 3 ASINs for 54.4% of Top 10 volume. Good Molecules follows with 40,000 units (16.7%), ahead of ANUA on 30,000 units (12.6%).

With 6 brands splitting the Top 10 and 83.7% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $10.65 to $23.45, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, one ASIN forced its way in: B0GZ19T1SM booked 10K units at $39.00, with ▲ 66.7% MoM change. On the growth side, B0GJPWPN6R leads positive momentum with ▲ 566.7% MoM growth on 2K units, with B0FR381VD2 close behind at ▲ 500.0% MoM on 300 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.